ArticlePharmaceuticals (Basel, Switzerland)2024

Gefitinib-Induced Severe Dermatological Adverse Reactions: A Case Report and Pharmacogenetic Profile.

Mariana Vieira Morau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.